PREP Audio - Genetics: Early Dx, Early Rx
April 2008, Volume 3, No. 4

Genetics: Early Dx, Early Rx

Genetics: Early Dx, Early Rx

Learning Objectives

  • To define and understand investigative genetics.
  • To determine the impact of the Human Genome Project.
  • To understand polymorphisms.
  • To apply the findings of the Human Genome Project to pharmacogenetics.
  • To explore the lysosomal storage diseases for which there are options for early diagnosis and treatment.
Genetics: Early Dx, Early Rx

Gregory A. Grabowski, MD, FAAP

Current Source of Funding from Research Grants: Amicus Therapeutic. Current Sources of Funding from Consulting: Genzyme Corporation and TKT/Shire Pharmaceuticals. This issue does not contain a discussion of unapproved/investigative use of a commercial product/device.

Genetics: Early Dx, Early Rx

Seymour MD

Dr. Packman disclosed no financial relationship relevant to this issue. This issue does not contain a discussion of unapproved/investigative use of a commercial product/device.

Genetics: Early Dx, Early Rx

Majed J. Dasouki, MD

Dr. Dasouki disclosed no financial relationship relevant to this issue. This issue does not contain a discussion of unapproved/investigative use of a commercial product/device.